Factors associated with advanced disease stage at diagnosis in a population-based study of patients with newly diagnosed breast cancer

被引:96
作者
Hahn, Karin M. E.
Bondy, Melissa L.
Selvan, Mano
Lund, Mary Jo
Liff, Jonathan M.
Flagg, Elaine W.
Brinton, Louise A.
Porter, Peggy
Eley, J. William
Coates, Ralph J.
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Breast Med Oncol & Epidemiol, Houston, TX 77230 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77230 USA
[3] Univ Texas, MD Anderson Canc Ctr, Dept Qual Improvement, Houston, TX 77230 USA
[4] Emory Univ, Winship Canc Inst, Atlanta, GA USA
[5] Emory Univ, Rollins Sch Public Hlth, Dept Epidemiol, Atlanta, GA USA
[6] Natl Ctr HIV,STD & TB Prevent, Ctr Dis Control & Prevent, Div Std HIV Prevent, Atlanta, GA USA
[7] Natl Canc Inst, Hormonal & Reproduct Epidemiol Branch, Bethesda, MD USA
[8] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA USA
[9] Ctr Dis Control & Prevent, Div Canc Prevent & Control, Atlanta, GA USA
关键词
body mass index; breast neoplasms; demography; ethnic groups; socioeconomic factors;
D O I
10.1093/aje/kwm177
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Breast cancer is diagnosed at a younger age and a more advanced stage in African-American women than in White women. The authors investigated the effects of several factors, including race, on stage of breast cancer in women aged 20-54 years living in Atlanta, Georgia, and diagnosed between 1990 and 1992. A total of 251 African-American and 580 White women were interviewed and their medical records reviewed. By use of polytomous logistic regression, factors possibly influencing stage and racial differences in stage were studied. In African-American women, the odds of stage III/IV breast cancer at diagnosis were almost four times the odds in White women (odds ratio = 3.79, 95% confidence interval: 2.45, 5.89) and approximately two and one-half times for stage IIA or stage IIB disease (odds ratio = 2.57, 95% confidence interval: 1.66, 3.99; odds ratio = 1.94, 95% confidence interval: 1.31, 2.86, respectively). These racial differences appeared to be largely explained by insurance status, poverty, history of mammography, method of tumor detection, and obesity. Interventions targeting these factors could potentially lower the stage at diagnosis for African-American breast cancer patients and, in doing so, improve their survival and other outcomes.
引用
收藏
页码:1035 / 1044
页数:10
相关论文
共 52 条
[21]  
FIGUEROA JB, 1995, AM ECON REV, V85, P112
[22]   Tumor characteristics in African American and white women [J].
Furberg, H ;
Millikan, R ;
Dressler, L ;
Newman, B ;
Geradts, J .
BREAST CANCER RESEARCH AND TREATMENT, 2001, 68 (01) :33-43
[23]   DELAY, STAGE OF DISEASE, AND SURVIVAL AMONG WHITE AND BLACK-WOMEN WITH BREAST-CANCER [J].
GREGORIO, DI ;
CUMMINGS, KM ;
MICHALEK, A .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1983, 73 (05) :590-593
[24]   Racial differences in diagnosis, treatment, and clinical delays in a population-based study of patients with newly diagnosed breast carcinoma [J].
Gwyn, K ;
Bondy, ML ;
Cohen, DS ;
Lund, MJ ;
Liff, JM ;
Flagg, EW ;
Brinton, LA ;
Eley, JW ;
Coates, RJ .
CANCER, 2004, 100 (08) :1595-1604
[25]   Histologic grade, stage, and survival in breast carcinoma [J].
Henson, DE ;
Chu, KC ;
Levine, PH .
CANCER, 2003, 98 (05) :908-917
[26]  
Hosmer W., 2000, Applied Logistic Regression, VSecond
[27]   BREAST-CANCER - FACTORS ASSOCIATED WITH STAGE AT DIAGNOSIS IN BLACK-AND-WHITE WOMEN [J].
HUNTER, CP ;
REDMOND, CK ;
CHEN, VW ;
AUSTIN, DF ;
GREENBERG, RS ;
CORREA, P ;
MUSS, HB ;
FORMAN, MR ;
WESLEY, MN ;
BLACKLOW, RS ;
KURMAN, RJ ;
DIGNAM, JJ ;
EDWARDS, BK ;
SHAPIRO, S .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (14) :1129-1137
[28]   Mammography screening and differences in stage of disease by race/ethnicity [J].
Jacobellis, J ;
Cutter, G .
AMERICAN JOURNAL OF PUBLIC HEALTH, 2002, 92 (07) :1144-1150
[29]   African American white differences in breast carcinoma - p53 alterations and other tumor characteristics [J].
Jones, BA ;
Kasl, SV ;
Howe, CL ;
Lachman, M ;
Dubrow, R ;
Curnen, MM ;
Soler-Vila, H ;
Beeghly, A ;
Duan, F ;
Owens, P .
CANCER, 2004, 101 (06) :1293-1301
[30]  
JONES BA, 1995, CANCER, V75, P2103, DOI 10.1002/1097-0142(19950415)75:8<2103::AID-CNCR2820750813>3.0.CO